Global lessons from the AIDS pandemic: Economic, financial, legal and political implications

Global Lessons from the AIDS Pandemic: Economic, Financial, Legal and Political Implications

Volumn , Issue , 2008, Pages 1-364

  Condon, Bradly J ^a   Sinha, Tapen ^a  

^a INSTITUTO TECNOLÓGICO AUTÓNOMO DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84891977257     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-540-78392-3     Document Type: Book

References (406)

1. Billings M (1997) The Influenza Pandemic of 1918. http://virus.stanford. edu/uda/. Accessed 6 September 2007
2. Dunham W (2007) Virulent form of cold virus spreads in U.S. Reuters, 15 November 2007
3. Gao F, Bailes E, Robertson DL, Chen Y et al. (1999) Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 397:436-444
4. McPherson S (2007) All eyes on Pakistan as H5N1 H2H transmission grows more probable. http://www.scottmcpherson.net/journal/2007/12/14/all-eyes-on- pakistan-as-h5n1-h2h-transmission-grows-more-pro.html. Accessed 14 December 2007
5. Nebehay S (2007) Mixed scenario seen behind Pakistan birdflu spread. http://www.reuters.com/article/latestCrisis/idUSL18866730. Accessed 19 December 2007
6. Rosenthal E (2007) As Earth Warms Up, Tropical Virus Moves to Italy. http://www.nytimes.com/2007/12/23/world/europe/23virus.html?hp. Accessed 23 December 2007
7. Sherman IW (2007) Twelve Diseases That Changed Our World. American Society for Microbiology Press, Washington, DC
8. Taubenberger JK, Morens DM (2006) 1918 Influenza: The Mother of all Pandemics. Emerging Infectious Diseases. http://www.cdc.gov/ncidod/EID/ vol12no01/05-0979.htm. Accessed 23 October 2007
9. Vandamme AM et al. (2003) Tracing the origin and history of the HIV-2 epidemic. Proceedings of the National Academy of Sciences of the United States of America 100(11): 6588-6592
10. Waters J (2007) Bird flu could have become worldwide pandemic: study. http://www.abc.net.au/news/stories/2007/08/31/2021231.htm. Accessed 31 August 2007
11. Wolfe ND, Switzer WM, Carr JK et al. (2004) Naturally acquired simian retrovirus infections in Central African Hunters. The Lancet 363:932
12. Zhou T, Korber B, Nahinias AJ (1998) An African HIV-1 sequence from 1959 and implications for the origin of the epidemic. Nature 391:594-597 (Pubitemid 28157602)
13. Baldwin K (2002) Latin American AIDS Activists Turn on Brazil. Reuters, 25 May 2002
14. Barbour AD (1975) The Duration of the Closed Stochastic Epidemic. Biometrika 62:478, Theorem 2:478-479
15. Boguna M, Pastor-Satorras R, Diaz-Guilera A, Arenas A (2003) Emergence of Clustering, Correlations, And Communities In A Social Network Model. Unpublished manuscript
16. Brazil Ministry of Health (2007) Boletim Epidemiológico 2007. http://www.aids.gov.br/data/Pages/ LUMISE77B47C8ITEMID2814D2BBCB3A4044A05D457001332BCFPTBRI E.htm. Accessed 27 November 2007
17. Camacho K (2006) Latin America seeks consensual approach to AIDS/STD. Agencia Brasil
18. Champ P, Attaran A (2002) Patent Rights and Local Working Under the WTO TRIPS Agreement: An Analysis of the US-Brazil Patent Dispute. Yale Journal of International Law 27:365
19. Chartrand S (2001) Patents: In Health Emergencies, Brazil Allows the Copying of Drugs. New York Times, 19 February 2001
20. Cooper H, Zimmerman R, McGinley L (2001) Drug Makers' Fight For Patent Rights Puts Them in a Vise-AIDS Suit in South Africa May Be a No-Win for Them-Industry Loses US Government's Backing. Wall Street Journal, 5 March 2001
21. Cullinan K (2004) Aids Infected by toxic ideas. Financial Mail, 7 May 2004
22. Daly K (2000) The Business Response to HIV/AIDS: Impact and Lessons Learned. Joint United Nations Program on HIV/AIDS
23. Department of Health and Ageing (2002) Return on Investment in Needle and Syringe Programs in Australia, report prepared by Health Outcomes International in association with the National Centre in HIV Epidemiology and Clinical Research and Professor Michael Drummond, Canberra
24. Dezso Z, Barabasi AL (2002) Halting viruses in scale-free networks. Physical Review E 2002 May;65(5 Pt 2):055103. Epub 2002 May 21
25. Galvao J (2002) Access to Antiretroviral Drugs in Brazil. The Lancet 360:1862-1865 (Pubitemid 35449428)
26. Gargoyles Inc. and Pro-Tec Inc. v. The United States (1997), 113 F 3d 1572. http://www.law.emory.edu/fedcircuit/may97/96-5089.html. Accessed 20 May 2004
27. Garrett L (2005) HIV and National Security: Where are the Links? Council on Foreign Relations, New York
28. Georgia-Pacific Corp. v. United States Plywood Corp. (1971) 318 F Supp 1116, 1120, 166 USPQ 235, 238 (SDNY), Modified and Affirmed, 446 F 2d 295, 302, 170 USPQ 369, 374 (2d Cir 1971)
29. Harris G (2001) Adverse Reaction: AIDS Gaffes in Africa Come Back to Haunt Drug Industry at Home-Price Cuts Abroad Deepen Domestic Trouble as Firms Reveal 'True' Cost of Pills-John le Carre's New Villain. Wall Str J 23 April 2001
30. Health News (2007) Thai HIV Activists Scale up Protests Against AIDS Drug Blockade. http://news.monstersandcritics.com/health/news/article-1333921. php. Accessed 24 July 2007
31. Hughes Aircraft Co. v. United States (1996) 86 F 3d 1566, 1571-72, 39 USPQ 2d 1065, 1069 (Fed Cir 1996)
32. International Treatment Preparedness Coalition (2007) Missing the Target #5: Improving AIDS Drug Access and Advancing Health Care for All. http://www.aidstreatmentaccess. org/itpc5th.pdf. Accessed 15 December 2007
33. Kaiser Daily HIV/AIDS Report (2007) Thailand Will Not Issue Compulsory Licenses for Patented Drugs if Pharmaceutical Companies Match Generic Prices, Health Minister Says. http://www.kaisernetwork.org/daily-reports/rep-index.cfm? DR-ID=44931. Accessed 18 May 2007
34. Kazmin A, Jack A (2007) Thailand Confirms Switch to Generic Drugs. Financial Times, 29 January 2007
35. Kihara M et al. (2003) HIV Surveillance in Japan 1984-2000. Journal of the Acquired Immune Deficiency Syndrome 35:S55-S63
36. Lanjouw J (2001) A Patent Policy Proposal for Global Diseases. The Brookings Institution. http://www.brook.edu/views/papers/lanjouw/20010611.htm. Accessed 24 July 2004
37. Leesona Corp. v. United States (1979) 599 F.2d 958, 966, 202 USPQ 424, 432-33 (Ct. Cl. 1979)
38. Love J (1999) Congressional Testimony. www.house.gov/reform/cj/hearings/ 99.7.22/Love.htm. Accessed 24 May 2004
39. McNeil DG Jr (1998) AIDS Stalking Africa's Struggling Economies. New York Times, 15 November 1998
40. Mindel A, Kippax S (2005) A National Sexually Transmissible Infections Strategy: The Need for an All-Embracing Approach. Medical Journal of Australia 183:10
41. Nemoto T (2004) HIV Surveillance and Prevention Studies in Japan. AIDS Education and Prevention, Special Supplement, June 2004, 27-42
42. Nemoto T et al. (2003) Potential Vector Toward High HIV Prevalence in Japan. Unpublished manuscript. University of California-San Francisco
43. Oliveira-Cruz V, Kowalski J, McPake B (2004) The Brazilian HIV/AIDS 'success story'-can others do it? Tropical Medicine and International Health 9:292-297 (Pubitemid 38250818)
44. Petersen M (2001) Roche Asks for Meeting With Brazil Health Minister. New York Times, 24 August 2001
45. Rhodes T, Ball A, Stimson G et al. (1999) HIV Infection Associated with Drug Injecting in the Newly Independent States, Eastern Europe: The Social and Economic Context of Epidemics. Addiction 94:1323-1336 (Pubitemid 29433791)
46. Rich JL (2001) Roche Reaches Accord on Drug with Brazil. New York Times, 31 August 2001
47. Rite-Hite Corp. v. Kelley Co (1995) 56 F 3d 1538, 1545, 35 USPQ 2d 1065, 1069 (Fed Cir) (in banc), cert denied, 116 S Ct 184
48. Rosenberg T (2001) Look at Brazil. New York Times, 28 January 2001
49. Santoro L (2007) Cheap HIV Drugs are More Important than Patents. LA Times. http://www.latimes.com/news/opinion/sunday/commentary/la-oe-santoro9 oct 09, 0, 7919978. story?coll=la-sunday-commentary. Accessed 9 October 2007
50. Shields M (2001) Drug Maker, Brazil Near Accord on AIDS Drug Price. Reuters, 23 August 2001
51. Sittitrai, W et al. (1992) Thai Sexual Behavior and the Risk of HIV Infection. Chulalongkorn University
52. Smith-Fawzi MC, Koenig SP, Castro A, Becerra MC, Sachs J, Attaran A, Kim JY (2001) Community-Based Approaches to HIV Treatment in Resource-Poor Settings. Lancet 358: 404-409 (Pubitemid 32739107)
53. Stone R (2007) Thai Health Minister Defends Controversial Drug-Patent Policy. Science 316:5830/1408
54. Tektronix Inc. v. United States (1977) 552 F 2d 343, 349, 193 USPQ 385, 391 (Ct Cl), modified, 557 F 2d 265 (Ct Cl 1977)
55. Ten Kate D (2007) Calling Mr. Condom: Thailand Renews Prevention Efforts to Stem an Uptick in HIV Infections. Asia Sentinel. http://www.asiasentinel.com/ index.php? option=com-content&task=view&id=761&Itemid=31. Accessed 12 October 2007
56. Thai Ministry of Public Health (2007) Facts and Evidences on the 10 Burning Issues Related to the Government Use of Patents on Three Patented Essential Drugs in Thailand. http://www.moph.go.th/hot/White%20Paper%20CL-EN. pdf. Accessed 25 November 2007
57. 't Hoen E (2002) TRIPS, Pharmaceutical Patents, and Access to Essential Medicines: A Long Way From Seattle to Doha. Chicago Journal of International Law 3:27
58. UNAIDS (2005) On the Frontline. http://data.unaids.org/UNA-docs/Report- SHR-OnFrontLine-18 july05-en.pdf?p. Accessed 27 June 2006
59. UNAIDS (2007) 2007 AIDS epidemic update. http://data.unaids.org/pub/ EPISlides/2007/2007-epiupdate-en.pdf. Accessed 30 November 2007
60. Uneklabh C et al. (1989) Prevalence of HIV Among Drug Users in Thailand. Paper Presented at the Fourth International Conference on AIDS, Stockholm, Sweden
61. Weaver H, Smith G, Kippax S (2005) School-Based Sex Education Policies and Indicators of Sexual Health among young people: a Comparison of the Netherlands, France, Australia and the United States. Sex Education: Sexuality, Society and Learning 5:171-188 (Pubitemid 41664660)
62. World Bank (2004) Project Performance Assessment Report Brazil. Report No. 28819, April 2004
63. Weniger BG (2006) Epidemiology of HIV Infection in Thailand, AIDS 5: S65-S71
64. WHO (2000) HIV, TB and Malaria-Three Major Infectious Disease Threats. Backgrounder No. 1 July 2000
65. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A (2005) Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 trial. PLoS Medicine 2:298
66. Aventin L, Huard P (2000) The cost of AIDS to three manufacturing firms in Côte d'Ivoire. Journal of African Economics 9:161-188 (Pubitemid 30454517)
67. Bailey RC (2007) Male Circumcision: The Road from Evidence to Practice. Division of Epidemiology, School of Public Health, University of Illinois at Chicago
68. Bautista S, Dmytraczenko T, Kombe G, Bertozzi S (2003) Antiretroviral Treat-ment Costs in Mexico. WHO/UNAIDS Workshop on Strategic Information for Anti-Retroviral Therapy Programmes, 2 July 2003
69. Bernstein Research (2005) Life settlements need not be unsettling, July 20, New York
70. Bergstrom R (2005) The protection value of oral fluid testing. On the Risk 21:63-64
71. Bloom DE, Mahal A, and River Path Associates (2002) HIV/AIDS and the Private Sector-A Literature Review. American Foundation for AIDS: Washington, DC
72. Daykin C, Eves M, Clark P, Haberman S et al. (1988) The Impact of HIV Infection and AIDS on Insurance in the United Kingdom. Journal of the Institute of Actuaries 115: 727-837
73. Doll DC (1997) AIDS Death Claims on Ordinary Life Insurance. Product Development News, Society of Actuaries, May 1997, pp. 4
74. Hellinger FJ, Fleishman JA (2000) Estimating the national cost of treating people with HIV disease: patient, payer, and provider data. Journal of Acquired Immune Deficiency Syndromes 24:182-188 (Pubitemid 30640966)
75. Keir D (2001) HIV/AIDS in South Africa. Life Convention, 18-20 November 2001, Birmingham Hilton Metropole, UK
76. Keisera O, Taffe P, Zwahlen M, Battegay M, Bernasconi E, Weber R, Rickenbach M (2004) All cause mortality in the Swiss HIV cohort study from 1990 to 2001 in comparison with the Swiss population. AIDS 18:1835-1843 (Pubitemid 39179636)
77. Medical News Today (2007) Washington, D.C., Releases New Data On HIV/AIDS. http://www.medicalnewstoday.com/articles/89856.php. Accessed 27 November 2007
78. Montaner JS, Reiss P, Cooper D, Vella S, Harris M, Conway B, Wainberg MA, Smith D, Robinson P, Hall D, Myers M, Lange JM (1998) A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study. JAMA 279:930-937 (Pubitemid 28136082)
79. Morbidity and Mortality Weekly Report (1991) Update: transmission of HIV infection during an invasive dental procedure-Florida. 18 January 1991
80. Ramachandran V, Shah MK, Turner G (2006) Does the Private Sector Care About AIDS? Evidence from Investment Climate Surveys in East Africa. Working Paper, Georgetown University, Washington
81. Ramaroson M (2003) The Human Right of HIV Positive Persons to Non-discrimination in Getting Life Insurance in South Africa. LL.M. Thesis, University of Pretoria
82. Rice BD, Bätzing-Feigenbaum J, Hosegood V, Tanser F, Hill C, Barnighausen T, Herbst K, Welz T, Newell ML (2007) Population and antenatal-based HIV prevalence estimates in a high contracepting female population in rural South Africa. BMC Public Health 7:160-176
83. Rosen S, Feeley F, Connelly P, Simon J (2007) The private sector and HIV/AIDS in Africa: taking stock of 6 years of applied research. AIDS 21:S41-S51 (Pubitemid 47220511)
84. Sabin L (2003) Corporate Responsibility in a World of AIDS: The Economic Case for Investing Now. Center for International Health and Development, Boston University School of Public Health, Boston
85. Simon J (2005) HIV/AIDS and its Impacts on African Labor Markets. Center for International Health and Development, Boston University School of Public Health, Boston
86. Sood, N (2003) Cashing Out Life Insurance: An Analysis of the Viatical Settlements Market, the RAND Graduate School Dissertation, Santa Monica, California
87. Wilson D (2007) The Evolving HIV Epidemic: What Have We Learned Since the MAP Began? World Bank, Washington
88. Yazdanpanah Y, Sissoko D, Egger M, Mouton Y, Zwahlen M, Chêne G (2004) Clinical efficacy of antiretroviral combination therapy based on protease inhibitors or non-nucleoside analogue reverse transcriptase inhibitors: indirect comparison of controlled trials. British Medical Journal 328:249
89. Zaheer K (2007) HIV cases highly overestimated, survey shows. Reuters, 6 July 2007
90. Zwahlen M, Egger M (2006) Progression and mortality of untreated HIV-positive individuals living in resource-limited settings: Update of literature review and evidence synthesis. UNAIDS, Obligation HQ/05/422204
91. Acemoglu D, Johnson S (2005) Disease and Development: The Effect of Life Expectancy on Economic Growth. Mimeo, MIT, Cambridge
92. Ainsworth M, Over M (1995) AIDS and African Development. World Bank Research Observer 9:203-241
93. Bearman PS, Brückner H (2001) Promising the Future: Virginity Pledges and First Intercourse. American Journal of Sociology 106:859-912
94. Bell C, Devarajan S, Gersbach H (2004) Thinking About the Long-Run Economic Costs of AIDS. In: Haacker M (ed) The Macroeconomics of HIV/AIDS. IMF, Washington
95. Bils M, Klenow P (2000) Does Schooling Cause Growth? American Economic Review 90:1160-1183
96. Biswalo PM, Lie GT (1995) Hospital-Based Counselling of HIV-Infected People and AIDS Patients. In: Klepp KI, Biswalo PM, Talle A (eds) Young People at Risk: Fighting AIDS in Northern Tanzania. Scandinavian University Press, Oslo
97. Bleakley H (2003) Disease and Development: Evidence from the American South. Journal of European Economic Association 1:376-386
98. Bleakley H, Lange F (2005) Chronic Disease Burden and the Interaction of Education, Fertility and Growth. UCSD Mimeo
99. Bloom D, Mahal A (1997) Does the AIDS Epidemic Threaten Economic Growth. Journal of Econometrics 77:105-124 (Pubitemid 127381048)
100. Bloom D, Mahal A (2001) HIV/AIDS and the Private Sector: A Literature Review. River Path Associates, American Foundation for AIDS, Washington, DC
101. Boldrin M, Jones LE (2002) Mortality, Fertility, and Saving in a Malthusian Economy. Review of Economic Dynamics 5:775-814
102. Bonnel R (2000) HIV/AIDS: Does it Increase or Decrease Growth in Africa? Mimeo, World Bank, Washington
103. Botswana Sentinel Survey (2001) Botswana Government Publication, Gaborone, Botswana
104. Bryce J, Black RE, Walker N, Bhutta ZA, Lawn JE, Steketee RW (2005) Can the world afford to save the lives of 6 million children each year? Lancet 365:2193-2200 (Pubitemid 40853912)
105. Chakraborty S (2004) Endogenous Lifetime and Economic Growth. Journal of Economic Theory 116:34-67
106. Chin (1994) A Beginner's Guide to EPIMODEL, Version 2.1, University of California, Berkeley
107. Clark G (2005) The Long March of History: Farm Laborers Wages in England 1208-1840. Working Paper, University of California-Davis
108. Cohen B (1998) The Emerging Fertility Transition in Sub-Saharan Africa. World Development 26:1431-1461 (Pubitemid 29004374)
109. Cohen D (2002) Human Capital and the HIV Epidemic in Sub-Saharan Africa. World Bank, Washington
110. Congressional Budget Office (2006) A Potential Influenza Pandemic: Possible Macro-economic Effects and Policy Issues. Congressional Budget Office, Washington, DC
111. Corrigan P, Glomm G, Mendez F (2005) AIDS Crisis and Growth. Journal of Development Economics 77(1):107-124
112. Darby P (2003) The Economic Impact of SARS. The Conference Board of Canada
113. David A (2007) Social Capital, HIV/AIDS, Economic Development. World Bank Policy Research Working Paper 4263
114. Doepke M (2005) Child Mortality and Fertility Decline: Does the Barro-Becker Model Fit the Facts? Journal of Population Economics 18:337-366 (Pubitemid 41406919)
115. Ehrlich I, Lui FT (1991) Intergenerational Trade, Longevity, Intrafamily Transfers and Economic Growth. Journal of Political Economy 99:1029-1059
116. Gray R (2005) Lessons from Africa. Presentation at the International AIDS Society Conference, Rio de Janeiro
117. Green G (1994) The reproductive careers of a cohort of men and women following an HIV positive diagnosis. Journal of Biosocial Science 26:409-415 (Pubitemid 24211213)
118. Guinness L, Kumaranayake L, Hanson K (2007) A Cost Function for HIV Prevention Services: Is There a 'U' Shape? Cost Effectiveness and Resource Allocation 5:5(1)
119. Haacker M (2002) The Economic Consequences of HIV/AIDS in South Africa. IMF Working Paper, IMF, Washington, DC
120. Halperin D (2007) AIDS Prevention: What Works? Washington Post 22 October 2007 A23
121. Hellinger F (1998) Cost and Financing of Care for Persons with HIV Disease. Health Care Financing Review 19:5-18 (Pubitemid 28530196)
122. Holtgrave DR, Crosby RA (2003) Social Capital, Poverty, and Income Inequality as Predictors of Gonorrhea, Syphilis, Chlamydia and AIDS Case Rates in the United States. Sexually Transmitted Infections 79:62-64 (Pubitemid 36237830)
123. Human Rights Watch (2005) The Less They Know, the Better: Abstinence-Only HIV/AIDS Programs in Uganda. March 17:4(A)
124. Husain IZ, Badcock-Walters P. Economics of HIV/AIDS mitigation: responding to problems of systemic dysfunction and sectoral capacity. In: Forsythe S, ed. State of the art: AIDS and economics. Washington, DC, Policy Project, 2002:84-95.
125. Juhn C, Kalemli-Ozcan S, Turan B (2007) HIV and Fertility in Africa: First Evidence from Population Based Surveys. Working Paper, December
126. Kalemli-Ozcan S (2006) AIDS, Reversal of the Demographic Transition and Economic Development: Evidence from Africa. Working Paper 12181, National Bureau of Economic Research
127. Kasyate S (2005) The Less They Know the Better: Abstinence Only HIV/AIDS Program in Uganda, Human Rights Watch, March 2005 Vol. 17, No. 4 (A)
128. Klitsch M (1992) Rural Ugandan Women's HIV Infection Rates Seem Related to Truck Routes. International Family Planning Perspectives 18:79
129. Kyomuhendo S, Ssempa M, Lamulatu L, Langa S, Kiwanuka J, Green EC (2004) Uganda National Abstinence and Being Faithful Policy And Strategy On Prevention Of Transmission of HIV/AIDS. Uganda AIDS Commission, Kampala
130. Lee JW, McKibbin W (2003) Globalization and Disease: The Case of SARS. Working Paper No. 2003/16, Australian National University
131. Lipsitz A Bishop PD Robinson C (2003) Virginity Pledges: Who takes them and how well do they work? Poster presented at: 15th Annual Convention of the American Psychological Society May 31 Atlanta, Georgia
132. Lorentzen P, McMillan J, Wacziarg R (2004) Death and Development. Mimeo, Stanford University
133. Luke N, Munshi K (2004) New Roles for Marriage in Urban Africa: Sexual Activity and Labor Market Outcomes in Kisumu. Mimeo, Brown University
134. McNeill W (1976) Plagues and People. Doubleday Publishing Company, New York
135. McPherson MF (2007) Can a Developing Country Support the Welfare Needs of Children Affected by AIDS? Paper submitted to the Joint Learning Initiative on Children and AIDS
136. Meltzer D (1992) Mortality Decline, the Demographic Transition and Economic Growth. PhD Dissertation, University of Chicago
137. Moore M, Viscusi K (1988) Doubling the Estimated Value of Life: Results using New Occupational Facility Data. Journal of Policy Analysis and Management 7:476-490
138. Mosley H (2005) The ABC's of AIDS Prevention: What's the Controversy? Johns Hopkins University, CCIH Conference
139. Muntaner C, Lynch J (2002) Social Capital, Class Gender and Race Conflict, and Population Health: An Essay Review of Bowling Alone's Implications for Social Epidemiology. International Journal of Epidemiology 31:261-267
140. Okware S (2007) Opportunities and Challenges in HIVAIDS Prevention and Control. International Workshop on Strengthening Capacity for HIV/AIDS Treat-ment and Care in West and East Africa, Kampala
141. Oster E (2005) Sexually Transmitted Infections, Sexual Behavior, and the HIV/AIDS Epidemic. Quarterly Journal of Economics 120:467-514
142. Oster E (2006) Measuring the Magnitude of HIV in Africa, " Working Paper, University of Chicago, November, 2006
143. Oster E (2007a) HIV and Sexual Behavior Change: Why not Africa? Working Paper, University of Chicago
144. Oster E (2007b) Routes of Infection: Exports and HIV Incidence in Sub-Saharan Africa. Working Paper, University of Chicago
145. Over M (1992) The Macroeconomic Impact of AIDS in Sub-Saharan Africa. World Bank Working Paper
146. Papageorgiou C, Stoytcheva P (2004) What Do We Know About the Impact of AIDS on Cross-Country Income So Far? Mimeo, LSU
147. Peterson A (2003) Testimony of Dr. Anne Peterson, USAID Assistant Administrator for Global Health before the Subcommittee on African Affairs, Committee on Foreign Rela-ations, http://www.usaid.gov/press/speeches/2003/ ty030519.html. May 19, 2003
148. Poulin MA, Muula S (2007) Male Circumcision and HIV Infection: The Case of Malawi. Working Paper, Princeton University
149. Putnam RD (2000) Bowling alone: the collapse and revival of American community. Touchstone, New York
150. Steinbrook R (2007) HIV In India-A Complex Epidemic. New England Journal of Medicine 356:1089-1093
151. Stover J et al. (2006) The Global Impact of Scaling-Up HIV/AIDS Prevention Programs in Low-and Middle-Income Countries 2006 Mar 10, 311:1474-1476
152. US Personal Responsibility and Work Opportunity Reconciliation Act of 1996 http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=104-con g-bills&docid=f:h3734enr.txt. pdf. Accessed 30 December 2007
153. USAID (2002) The "ABCs" of HIV Prevention: Report of a USAID Technical Meeting On Behavior Change Approaches To Primary Prevention of HIV/AIDS US Agency for "ABC" Experts Technical Meeting, International Development, Washington
154. Werker E, Ahuja A, Wendell B (2006) Male Circumcision and the Economic Impact of AIDS in Africa. Mimeo, Harvard Business School
155. WHO (2005) Estimating the Cost of Scaling-up Maternal and Newborn Health Interventions to Reach Universal Coverage: Methodology and Assumptions. Technical Working Paper
156. World Bank (2006) Second National HIV/AIDS Control Project for India
157. Young A (2005) The Gift of the Dying: The Tragedy of AIDS and the Welfare of Future African Generations. Quarterly Journal of Economics 120:423-466 (Pubitemid 40801677)
158. Young A (2006) In Sorrow to Bring Forth Children: Fertility Amidst the Plague of HIV. Mimeo, University of Chicago
159. Barfield CE, Groomridge MA (1999) Parallel Trade in the Pharmaceutical Industry: Implications for Innovation, Consumer Welfare and Health Policy. Fordham Intellectual Property Media and Entertainment Law Journal 10:185-265
160. Barton JH (2001) The Economics of TRIPS. The George Washington International Law Review 33:473-501
161. Bhagwati J (1994) Comment on Bernard Hoekman, Liberalizing Trade in Services. In Collins S, Bosworth BP (eds) The New GATT: Implications for the United States, The Brookings Institution, Washington, DC
162. Boldrin M, Levine D (2002) The Case against Intellectual Property. The American Economic Review 92:209-213
163. Boldrin M, Levine D (2008) Against Intellectual Property. Cambridge University Press, Cambridge
164. Book RA (2002) Public Research Funding and Private Innovation. PhD thesis, University of Chicago. home.uchicago.edu/~rbook/Book-PharmInnov.pdf. Acces-sed 2 June 2005
165. DiMasi JA, Hansen RW, Grabowski HG, Lasagna L (1991) Cost of Innovation in the Pharmaceutical Industry. Journal of Health Economy 10:107-142
166. DiMasi JA, Hansen RW, Grabowski HG (2001) The Price of Innovation: New Estimates of Drug Development Costs. Journal of Health Economy 22:167
167. DND Working Group (2001) Fatal Imbalance: The Crisis in Research and Development for Drugs for Neglected Diseases. MSF Access to Essential Medicines Campaign 171
168. Doctors without Borders (2003) A Progress Report on TRIPS. http://www.doctorswithoutborders.org/publications/reports/2003/cancun-report. pdf. Accessed 5 May 2004
169. Doherty P (2005) Interview, St. Jude Children's Research Hospital, Memphis, TN
170. European Union (2001) http://www.europarl.eu.int/meetdocs/committees/ juri/20010514/437115en.pdf. Accessed 5 July 2003
171. Flynn S, Palmedo M (2007) PIJIP Comments on the Korus FTA Pharmaceuticals and IP Chapters. http://lists.essential.org/pipermail/ip-health/2007-May/ 011282.html. Accessed 10 September 2007
172. Frankel S (2008) The Legitimacy and Purpose of Intellectual Property Chapters in FTAs. In: Buckley R, Lo VI, Boulle L (eds) Challenges to Multilateral Trade: The Impact of Bilateral, Preferential and Regional Agreements. Kluwer, The Hague
173. Gagnon MA, Lexchin J (2008) The Cost of Pushing Pills: A New Estimate of Pharmaceutical Promotion Expenditures in the United States. PloS Medicine 5(1): e1 doi: 10 1371/journal.pmed.0050001
174. Government Reform Committee Minority Staff (2005) Trade Agreements and Access to Medications under the Bush Administration. http://www.democrats. reform.house.gov. Accessed 11 September 2007
175. Hall BH (2001) The Global Nature of Intellectual Property: Discussion. Mimeo, Toronto IP Conference, May 2001
176. Hamburger T (2003) US Flip on Patents Shows Drug Makers' Growing Clout-Political Donors Get Help in Reversing Policy On Poor Nations' Access to Cheaper Medicine, Wall Street Journal, 6 February 2003, A4
177. Hestermeyer HP (2007) Canadian-Made Drugs for Rwanda: The First Application of the WTO Waiver on Patents and Medicines, ASIL Insight 11:28
178. Khan ZB (2006) The Democratization of Invention: Patents and Copyrights in American Economic Development, 1790-1920. Cambridge University Press, Cambridge
179. Knox D, Richardson M (2002) Trade Policy and Parallel Imports. European Journal of Political Economy 19:133
180. Kournikakis B, Armour SJ, Boulet CA, Spence M, Parsons B (2001) Risk Assessment of Anthrax Threat Letters. Defence R&D Canada. Technical Report DRES-TR-2001-048, September 2001
181. Kremer M (2001) Creating Markets for New Vaccines, parts I and II. Mimeo, Harvard University
182. Kucinich, Michaud, Grijalva, Lee, Waters, Brown, Evans, Stark, Allen (US Congress Representives) (2006), Letter to USTR Concerning CAFTA Implementation in Guatemala. http://www.cptech.org/ip/health/trade/cafta/ representatives04072006.pdf. Accessed 11 September 2007
183. Lancet Editorial (2001) Patent Protection Versus Public Health. The Lancet 358:1563
184. Lanjouw J (2001) A Patent Policy Proposal for Global Diseases. The Brookings Institution, http://www.brook.edu/views/papers/lanjouw/20010611.htm. Accessed 11 September 2004
185. Lanjouw J (2003) The Dialogue Continues, Latin American Advisor, 5 September 2003, www.thedialogue.org. Accessed 8 September 2003
186. National Institute for Health Care Management Research and Educational Foundation (2003) Changing Patterns of Pharmaceutical Innovation. www.nihcm.org/innovations.pdf. Accessed 15 November 2007
187. Oxfam (2007) All Costs, No Benefits: How TRIPS-Plus Intellectual Property Rules in the US-Jordan FTA Affect Access to Medicines. Oxfam Briefing Paper #102. http://www.oxfam.org/en/files/bp102-jordan-us-fta.pdf/. Accessed 25 November 2007
188. Peeters M, Sharp PM (2000) Genetic Diversity of HIV-1: The Moving Target. AIDS 14: S129-S130
189. PhRMA (2003) The PhRMA Industry Profile. www.phrma.org/publications/ publica-tions/profile02/chapter3.pdf, p 30. Accessed 17 February 2003
190. Pollock Allyson M, David Price (2003) New Deal from the World Trade Organisation May not Provide Essential Medicines for Poor Countries. British Medical Journal 327:572
191. Quah D (2002) 24/7 Competitive Innovation. econ.lse.ac.uk/staff/dquah/p/ 0204-247-2pp.pdf. Accessed 15 November 2004
192. Scherer FM, Watal J (2001) Post-TRIPS Options for Access to Patented Medicines in Developing Countries. Commission on Macroeconomics and Health, Working Paper WG4-1
193. Scotchmer S (2003a) The Political Economy of the Intellectual Property Treaties. National Bureau of Economic Research, Working Paper.
194. Scotchmer S (2003b) Political Economy of Intellectual Property Rights, Working Paper, National Bureau of Economic Research, Working Paper.
195. Scotchmer S (2004) Intellectual Property in the Global Economy. In: Scotchmer S (ed) Innovation and Incentives. MIT Press, Cambridge
196. Stigler G (1971) The Theory of Economic Regulation. Bell Journal of Economics and Management Science 2:3-21
197. Smetter K (2005) Interview at Wharton School, University of Pennsylvania
198. Survey of Private Sector Drug Research and Development (2003) www.neglecteddiseases.org/4-1.pdf. Accessed 5 June 2004
199. The Economist (2001) Patently Absurd? Economist 359/8227:40
200. Trouiller P, Olliaro P, Torreele E, Orbinski J, Laing R, Ford N (2002) Drug Development for Neglected Diseases: A Deficient Market and a Public-Health Policy Failure. The Lancet 22:2188-2194 (Pubitemid 34694030)
201. UNDP (1999) Human Development Report. www.undp.org. Accessed 6 May 2001
202. USTR (2007) Bipartisan Agreement on Trade Policy: Intellectual Property Provisions. http://www.ustr.gov/assets/Document-Library/Fact-Sheets/2007/asset- upload-file312-112 83.pdf. Accessed 10 November 2007
203. USTR (2007a) 2007 Special 301 Report, http://www.ustr.gov/assets/Docu- ment-Library/Reports-Publications/2007/2007-Special-301-Review/ asset-upload-file230-11122. pdf. Ac-Accessed 10 November 2007
204. Walter I (2003) Global Financial Stability Report. Market Developments and Issues, International Monetary Fund, Washington DC
205. WTO (2007a) International trade statistics 2007, Table I.9, Leading exporters and importers in world merchandise trade (excluding intra-EU (25) trade), 2006. http://www.wto. org/english/res-e/statis-e/its2007-e/its07-world- trade-dev-e.htm. Accessed 15 November 2007
206. WTO (2007b) International trade statistics 2007, Table I.10, Leading exporters and importers in world trade in commercial services, 2006. http://www.wto.org/english/res-e/statis-e/its2007-e/its07-world-trade-dev-e.htm. Accessed 15 November 2007
207. Arruñada B, Andonova V (2005) Market Institutions and Judicial Rulemaking. In: Ménard C, Shirley M (eds) Handbook of New Institutional Economics. Springer, Berlin Heidelberg New York Attaran A (2007) A Tragically Naive Canadian Law for Tragically Neglected Global Health. http://www.cmaj.ca. Accessed 20 April 2007
208. Boldrin M, Levine D (2002) The Case Against Intellectual Property. The American Eco-nomy Review 209
209. Cahoy D (2007) Confronting Myths and Myopia on the Road from Doha. Georgia Law Review 42:131-192
210. Condon B, Sinha T (2005) Global Diseases, Global Patents and Differential Treatment in WTO Law: Criteria for Suspending Patent Obligations in Developing Countries, Northwestern. Journal of International Law and Business 26:1-35
211. Hestermeyer HP (2007) Canadian-made Drugs for Rwanda: The First Application of the WTO Waiver on Patents and Medicines. ASIL Insight 11:28
212. Khan BZ (2005) The Democratization of Invention: Patents and Copyrights in American Economic Development. Cambridge University Press, Cambridge
213. Lanjouw J (2003) A Patent Policy Proposal for Global Diseases. The Brookings Institution, http://www.brook.edu/views/papers/lanjouw/20010611.htm. Accessed 5 July 2005
214. Pastor-Satorras R, Vespignan A (2002) Epidemic Dynamics in Finite Size Scale-Free Networks. http://arxiv.org/abs/cond-mat/0202298. Accessed 25 July 2004
215. Peters M, Sharp, PM (2000) Genetic Diversity of HIV-1: The Moving Target. AIDS 14:S129-S130
216. Scotchmer S (2003) The Political Economy of Intellectual Property Treaties. National Bureau of Econ Research, Working Paper No. 9114
217. Stein E (2001) International Integration and Democracy: No Love at First Sight. American Journal of International Law 95:489-534
218. Trouiller P, Olliaro P, Torreele E, Orbinski J, Laing R, Ford N (2002) Drug Development for Neglected Diseases: A Deficient Market and a Public-Health Policy Failure. The Lancet 359:2188-2194 (Pubitemid 34694030)
219. Tsai J (2007) Not Tripping Over the Pebbles. Michigan State University Journal of Medicine and Law 11:427-450
220. UNDP (1999) Human Development Report. http://www.undp.org
221. WTO (2005) Amendment of the TRIPS Agreement, Decision of 6 December 2005, General Council, WT/L/641. http://www.wto.org/english/tratop-e/trips-e/wtl641- e.htm. Accessed 5 June 2006
222. WTO (2007) Notification under Paragraph 2(c) of the Decision of 30 August 2003 on the Implementation of Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health, Council for Trade-Related Aspects of Intellectual Property Rights, IP/N/10/CAN/1. http://www.wto.org/english/tratop-e/trips-e/ public-health-notif-export-e.htm. Accessed 5 July 2004
223. Alsan M, Bloom DE, Canning D (2004) The Effect of Population Health on Foreign Direct Investment. NBER Working Paper No. 10596, http://papers.nber.org/ papers/w10 596. Accessed 15 August 2005
224. BBC News (2007a) Shock at Archbishop Condom Claim. http://news.bbc.co.uk/ 2/hi/africa/7014335.stm. Accessed 26 September 2007
225. BBC News (2007b) HIV Treatment 'Failing' in Africa. http://news.bbc.co. uk/2/hi/africa/7046545.stm. Accessed 16 October 2007
226. Bloom DE, Mahal A, River Path Associates (2001) HIV/AIDS and the Private Sector-A Literature Review. http://www.psp-one.com/content/resource/detail/2612/ . Accessed 5 June 2006
227. Center for Global Development (2005) Private Sector Responses to HIV/AIDS: The Case of Debswana, Botswana's Diamond Company. http://www.cgdev. org/content/calendar/detail/4258/. Accessed 15 June 2006
228. Center for Global Development and Merck (2007) Can Public-Private Partnerships Help Stop AIDS in Africa? Lessons from Botswana. http://www.cgdev.org/content/calendar/detail/13758/. Accessed 5 September 2007
229. Dekay S (2004) Funding the Response to AIDS: Why are Donors not Working Together? 15th Annual International AIDS Conference, Bangkok http://www.kaisernetwork.org/health-cast/uploaded-files/071204-ias-funding.pdf. Accessed 5 June 2006
230. Easterly W (2006) The White Man's Burden. Penguin, New York
231. ECA Press Release (2003) African Ministers Pronounce on Aid, Trade, Debt, IMF, HIV/AIDS. http://www.uneca.org/eca-resources/press-releases/2003- pressreleases/pressre-lease0803.htm. Accessed 25 June 2007
232. England R, de Lay P, Greener R, Izazola JA(2007) Are we spending too much on HIV? British Medical Journal 334:344-345 (Pubitemid 46328043)
233. Euro Health Group (2007) Global Fund to Fight AIDS, Tuberculosis and Malaria: Evaluation of the Local Fund Agent System. http://www.theglobalfund. org/en/files/links-reesources/library/studies/specific-evaluations/ GFATM-Evaluation-of-LFA-Report. pdf. Accessed 7 January 2008
234. GAO (2007) Global Fund to Fight AIDS, TB and Malaria Has Improved its Documentation of Funding Decisions but Needs Standardized Oversight Expectations and Assessments. http://www.theglobalfund.org/en/files/links-resources/library/ studies/integrated-evaluations/d07627.pdf. Accessed 7 January 2008
235. GBC and Booz, Allen, Hamilton (2006) The State of Business and HIV/AIDS. http://www.businessfightsaids.org/atf/cf/%7B4AF0E874-E9A0-4D86-BA28- 96C3BC31180A% 7D/The%20State%20of%20Business%20and%20HIVAIDSFINAL.pdf. Accessed 19 October 2007
236. Global Fund (2003) The Framework Document of the Global Fund to Fight AIDS, Tuberculosis and Malaria. http://www.theglobalfund.org/en/files/publicdoc/ Framework-uk. pdf. Accessed 5 October 2007
237. Global HIV Prevention Working Group (2007) Bringing HIV Prevention to Scale: An Urgent Global Priority. http://www.globalhivprevention.org/pdfs/PWG- HIV-prevention-report-FINAL.pdf. Accessed 15 November 2006
238. Gonzalves G (2004) Funding the Response to AIDS: Why are Donors not Working Together? 15th Annual International AIDS Conference, Bangkok, 12 July 2004, http://www.kaisernetwork.org/health-cast/uploaded-files/071204-ias- funding.pdf. Accessed 5 June 2006
239. Hanlon J (1999) Pound of flesh: Joseph Hanlon Reports on How Local People have Wised up to a Huge International Hoax. New Internationalist, March 1999, http://findarticles.com/p/articles/mi-m0JQP/is-310/ai-30471475. Accessed 6 October 2007
240. Hanlon J (2006) Donor Concern over IMF Cap on Aid Increases. http://www.open.ac. uk/technology/mozambique/. Accessed 6 October 2007
241. IMF (2005) The IMF's Role in the Fight Against HIV/AIDS. http://www.imf.org/external/np/exr/facts/hivaids.htm. Accessed 16 October 2007
242. Kaberuka D (2007) The New International Aid Architecture: New Players, New Challenges, Old Problems? http://www.ideas4development.org/the-new- international-aid-architecture-new-players-new-challenges-old-problems/en/. Accessed 20 October 2007
243. Kasheeka EB, Bicego G, Gorgens-Albino M, Kemerer V, Nzima M (2006) Strengthening Partnerships in HIV Monitoring and Evaluation: How Joint Missions Build and Strengthen Partnerships to Support the Realization of National M&E systems. World Bank Working Paper, http://www-wds.worldbank.org. Accessed 5 August 2007
244. Kates J, Lief E (2006) International Assistance for HIV/AIDS in the Developing World: Taking Stock of the G8, Other Donor Governments, and The European Commission. Kaiser Family Foundation, Center for Strategic and International Studies/UNAIDS, data. unaids. org/pub/BaseDocument/2006/20060731- KFF-international-assistance-en.ppt. Accessed 6 November 2007
245. Kyama R, McNeil DG Jr (2007) Distribution of Nets Splits Malaria Fighters. www.nytimes.com. Accessed 9 October 2007.
246. Lee C et al. (2002) Global Fund Responsiveness to Faith-based Organizations. http://www.aidspan.org/documents/other/gfo33.pdf. Accessed 19 October 2007
247. Love B, Pattanaik S (2007) IMF must Adapt and Downsize or die, New Boss Says. Reuters, 2 October 2007
248. Lurie P, Hintzen P, Lowe RA (1995) Socioeconomic obstacles to HIV prevention and treatment in developing countries: The roles of the international monetary fund and the World bank. AIDS 9:539-546
249. McKai R (2004) Funding the Response to AIDS: Why are Donors not Working Together? 15th Annual International AIDS Conference, Bangkok, 12 July 2004, http://www.kaisernetwork.org/health-cast/uploaded-files/071204-ias-funding.pdf. Accessed 2 October 2007
250. McKinnell H (2004) Funding the Response to AIDS: Why are Donors not Working Together? 15th Annual International AIDS Conference, Bangkok, 12 July2004, http://www.kaisernetwork.org/health-cast/uploaded-files/071204-ias- funding.pdf. Accessed 8 October 2007
251. Médecins Sans Frontières (2005) Access to Healthcare, Mortality and Violence in Democratic Republic of the Congo. http://www. doctorswithoutborders.org/publications/reports/2005/drc-healthcare-11-2005.pdf. Accessed 20 October 2007
252. Mwale B (2004) Funding the Response to AIDS: Why are Donors not Working Together? 15th Annual International AIDS Conference, Bangkok, 12 July 2004, http://www.kaisernetwork.org/health-cast/uploaded-files/071204-ias-funding.pdf. Accessed 19 October 2007
253. Ndegwa A (2007) Kenya: Clinton Foundation Provides $38M for Children Living with HIV/AIDS. East Africa Standard, 16 October 2007, http://www.eastandard.net/archives/index. php?mnu=details&id= 1143976044&catid=159&PHPSESSID=8bf8ad663240a5985ae1e31 4fcb6c0f3. Accessed 23 October 2007
254. OECD (2005) The Paris Declaration. http://www.oecd.org/document/18/0, 2340, en-2649-3236398-35401554-1-1-1-1, 00.html. Accessed 3 October 2007
255. OECD (2006) Measuring Aid in support of HIV/AIDS control. http://www.oecd.org/dataoecd/35/52/37266050.pdf. Accessed 23 October 2007
256. Oomman N, Bernstein M, Rosenzweig S (2007) Following the Funding for HIV/AIDS: A Comparative Analysis of the Funding Practices of PEPFAR, the Global Fund and the World Bank MAP in Mozambique, Uganda and Zambia. http://www.cgdev.org/content/publications/detail/14569/. Accessed 29 October 2007
257. Oxfam (2006) In the Public Interest: Health, Education, and Water and Sanitation for all. http://www.oxfam.org/en/policy/briefingpapers/bp
258. Patel P (2004) Funding the Response to AIDS: Why are Donors not Working together? 15th Annual International AIDS Conference, Bangkok, 12 July 2004, http://www.kaisernet-work.org/health-cast/uploaded-files/071204-ias-funding.pdf. Accessed 12 October 2007
259. Perone P (2006) A Response to Joseph Hanlon's Recent Article, Donor Concern Over IMF Cap on Aid Increases. 7 February 2006, http://www.imf.org/ external/np/vc/2006/020706.htm. Accessed 15 October 2007
260. Philips M (2007) Making AIDS patients pay for their care: Why evidence does not change anything in international donor policies? In: Medicins sans Frontieres (ed) AIDS: Free Access to Treatment, a Public Health Necessity or an Economic Heresy?
261. Picard A (2007) Quarantine Sought for Harsh TB strain: Variant Poses 'Extreme Risk, ' Scientists Say. Globe and Mail, 23 January 2007
262. PriceWaterhouseCoopers (2003) HIV/AIDS: What is Business Doing? A Survey of the Business Community's Response to HIV/AIDS in Kenya, Tanzania, Uganda and Zambia. http://www.psp-one.com/content/resource/detail/2250/. Accessed 24 October 2007
263. Radelet S (Chair) (2006) Challenges and Opportunities for the New Executive Director of the Global Fund: Seven Essential Tasks. Center for Global Development, http://www.cgdev.org/content/publications/detail/10948/. Accessed 19 October 2007
264. Radelet S, Siddiqi B (2007) Global Fund grant programmes: an analysis of evaluation scores. Lancet 369:1807-1813 (Pubitemid 46783019)
265. Ramachandran V, Shah MK, Turner G (2005) HIV/AIDS and the Private Sector in Africa: Evidence from the Investment Climate Survey Data. http://rru.worldbank.org/documents/PSDBlog/AIDSpaperOct28.pdf. Accessed 19 October 2007
266. Reuters (2007) World Bank Chief Calls For New Direction For Lender. 21 October 2007
267. Sidibe M, Ramiah I, Buse K (2006) Alignment, harmonisation, and accountability in HIV/AIDS. Lancet 368:1853-1854 (Pubitemid 44779757)
268. Smith M (2007) To End an Epidemic: A Study of Foreign Aid and HIV/AIDS. International Relations Thesis, New York University
269. Technical Evaluation Reference Group (2007) Summary Paper on the Evaluation of the Local Fund Agent System. http://www.theglobalfund.org/en/ files/links-resources/library/studies/specific-evaluations/TERG-Summary-Paper. pdf. Accessed 7 January 2008
270. UNAIDS (2005) Final Report, Global Task Team on Improving AIDS Coordination Among Multilateral Institutions and International Donors (GTT). UNAIDS, Geneva
271. UNAIDS (2006) Effectiveness of Multilateral Action on AIDS: Harmonized Support to Scaling up the National Response. Report for 18th meeting of the UNAIDS Program Coordination board. UNAIDS, Geneva
272. Wilson D (2007) The Evolving HIV Epidemic: What Have We Learned Since the MAP Began? powerpoint presentation, 10 June 2007
273. World Bank (2003) HIV/AIDS in Central America: The Epidemic and Priorities for its Prevention. World Bank, Washington
274. World Bank (2005a) The World Bank's Global HIV/AIDS Program of Action. World Bank, Washington
275. World Bank (2005a) Committing to Results: Improving the Effectiveness of HIV/AIDS Assistance, An OED Evaluation of the World Bank's Assistance for HIV/AIDS Control. http://siteresources.worldbank.org/EXTIEGHIVAIDS/Resources/ hiv-complete-report.pdf. Accessed 3 October 2007
276. World Bank (2006) Reducing HIV/AIDS Vulnerability in Central America: regional HIV/AIDS situation and response to the epidemic. Working Paper, http://www-wds.worldbank.org/external/default/WDSContentServer/WDSP/IB/2007/02/ 02/000020953-20070202121215/Rendered/PDF/385440ENGLISH01nalOverview01PUBLIC1. pdf. Accessed 1 October 2007
277. World Bank (2007) Rwanda Multi-Country Aids Program (MAP): Em-powering Communities, Harmonizing Approaches, Working Paper. http://www-wds.worldbank. org/external/default/WDSContentServer/WDSP/IB/2007/09/07/000310607- 20070907114625/Rendered/PDF/406520RW0MAP0communities01PUBLIC1.pdf. Accessed 15 October 2007
278. World Bank (2007a) Our Commitment: The World Bank's Africa Region HIV/AIDS Agenda for Action 2007-2011. http://siteresources.worldbank.org/ EXTAFRREGTOPHIVA IDS/Resources/WB-HIV-AIDS-AFA-2007-2011-Advance-Copy.pdf. Accessed 19 October 2007
279. Akukwe C (2007) PEPFAR Reauthorization: Issues for Consideration. http://www.worldpress.org/print-article.cfm?article-id=3081&dont=yes. Accessed 12 October 2007
280. Amundsen EJ, Eskild A, Stigum H, Smith E, Aalen OO (2003) Legal access to needles and syringes/needle exchange programmes versus HIV counselling and testing to prevent transmission of HIV among intravenous drug users: A comparative study of Denmark, Norway and Sweden. European Journal of Public Health 13:252-258 (Pubitemid 37162949)
281. Asia Catalyst (2007) AIDS Blood Scandals: What China Can Learn from the World's Mistakes. http://www.asiacatalyst.org/AIDS-blood-scandals-rpt-0907. pdf. Accessed 14 November 2007
282. Associated Press (2006) AIDS Treatment Resolution Withdrawn at WHO Meeting Because of U.S. Opposition. http://www.iht.com/articles/ap/2006/09/22/ asia/AS-MED-WHO-Asia-AIDS.php. Accessed 25 September 2006
283. BBC World (2007) World Debate. 6 October 2007
284. Bernstein M, Hise SJ (2007) PEPFAR Reauthorization: Improving Transparency in U.S. Funding for HIV/AIDS. Center for Global Development, http://www.cgdev.org/content/publications/detail/14814. Accessed 7 January 2008
285. Calmy A (2004) MSF and HIV/AIDS: Expanding Treatment, Facing New Challenges. http://www.msf.org/msfinternational/invoke.cfm?component= article&objectid=E5803E3F-48C2-48D0-B63D8771711FB20A&method=full-html. Accessed 5 April 2007
286. Canadian Commission of Inquiry on the Blood System in Canada (Krever Commission). http://epe.lac-bac.gc.ca/100/200/301/hcan-scan/commission-blood- final-rep-e/vol1-e.pdf. Accessed 15 November 2007
287. Carter M (2007) PEPFAR Money Being used to 'Promote Homophobia', Charges Human Rights Group. http://www.aidsmap.com/en/news/B990E508-29C7-4F00-A995-9DA9 A58385FC.asp, Accessed 22 October 2007
288. CDC (2001) HIV Prevention Strategic Plan Through 2005. January 2001
289. CDC (2005) Syringe Exchange Programs. http://www.cdc.gov/idu/facts/aed- idu-syr. htm. Accessed 24 November 2007
290. CDC (2006) The State of CDC. http://www.cdc.gov/about/stateofcdc/cdrom/ SOCDC/SOCDC2006.pdf. Accessed 24 November 2007
291. CDC HIV Prevention Strategic Plan (2007), http://www.cdc.gov/hiv/ resources/reports/psp/pdf/psp.pdf. Accessed 24 November 2007
292. Day M (2007) Drug industry sponsorship: Who's funding WHO? British Medical Journal 334:338-340
293. Dekay S (2004) Funding the Response to AIDS: Why are donors not working together? 15th Annual International AIDS Conference, Bangkok, 12 July 2004, http://www.kaisernetwork.org/health-cast/uploaded-files/071204-ias-funding.pdf. Accessed 2 November 2007
294. Dubuet F, Tronc E (2006) United Nations: Deceptive humanitarian reforms? http://www.msf.org/msfinternational/invoke.cfm?objectid=95542E25-5056-AA77- 6C6F0623221C3658& component=toolkit.article&method=full-html. Accessed 4 November 2007
295. Fidler DP, Heymann DL, Ostroff SM, O'Brien TP (1997) Emerging and reemerging infectious diseases: Challenges for international, national, and state law. International Law 31:773
296. Fidler DP (1998) The future of the world health organization: What role for international Law? Vanderbilt Journal of Transnational Law 31:1079
297. Fillinger T (2006) U.S. Policies and their Health Impact on Women in Sup-Saharan Africa. University of Maryland Law Jurnal on Race, Religion, Gender and Class 6:337-352
298. Gibson DR (1998) HIV Prevention in Injection Drug Users, HIV InSite Knowledge Base Chapter. http://hivinsite.ucsf.edu/InSite?page=kb-07-04-01-01. Accessed 26 November 2007
299. Harris G (2007) Figures on H.I.V. Rate Expected to Rise. www.nytimes.com, 2 December 2007
300. Holtgrave DR, Kates J (2007) HIV incidence and CDC's HIV prevention budget: An exploratory correlational analysis. American Journal of Preventive Medicine 32:63-67 (Pubitemid 46048961)
301. Hurley SF et al. (1997) Effectiveness of needle-exchange programmes for prevention of HIV infection. Lancet 349:1797-1800 (Pubitemid 27257556)
302. Jarlais D et al. (2005) Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001. AIDS 19:3
303. Kahn JG (1993) Do NEPS affect rates of HIV drug and/or sex risk behaviors? In: Lurie P, Reingold AL et al. The Public Health Impact of Needle Exchange Programs in the United States and Abroad. Centers for Disease Control and Prevention, Atlanta
304. Kyama R, McNeil DG Jr (2007) Distribution of Nets Splits Malaria Fighters. www.nytimes.com, 9 October 2007
305. Lewis S (2007) Despite New Figures, Aids Funding Doesn't Meet Needs. http://allafrica.com/stories/200711231172.html. Accessed 23 November 2007
306. Magee J (2007) HIV Prevention, Harm Reduction, Injecting Drug Use. http://www.avert.org/injecting.htm. Accessed 14 November 2007
307. MSF (2006) Overview of MSF Operations-Audited Facts and Figures, http://www.msf.org/msfinternational/invoke.cfm?objectid=992D03D9-5056-AA77- 6C9F7BBBE 9771A9F&component=toolkit.article&method=full-html. Accessed 24 November 2007
308. Mwale B (2004) Funding the Response to AIDS: Why are donors not working together? 15th Annual International AIDS Conference, Bangkok, 12 July 2004, http://www.kaisernetwork.org/health-cast/uploaded-files/071204-ias-funding.pdf. Accessed 26 November 2007
309. Oomman N, Bernstein M, Rosenzweig S (2007) Following the Funding for HIV/AIDS: A Comparative Analysis of the Funding Practices of PEPFAR, the Global Fund and the World Bank MAP in Mozambique, Uganda and Zambia. http://www.cgdev.org/content/publications/detail/14569/. Accessed 7 November 2007
310. PEPFAR (2005) FY2006 Country Operation Plan (COP) Guidance for the President's Emergency Plan for AIDS Relief (PEPFAR). http://www.genderhealth. org/pubs/COP GuidanceFY06.pdf. Accessed 14 November 2007
311. PEPFAR Fact Sheet (2007) http://www.stopaidsnow.org/documents/PEPFAR- facts. pdf. Accessed 14 November 2007
312. Philips M (2007) Making AIDS patients pay for their care: Why evidence does not change anything in international donor policies? In: Medicins sans Frontieres, AIDS: Free Access to Treatment, a Public Health Necessity or an Economic Heresy?
313. Ruger JP (2005) Global Functions at the World Health Organization. British Medical Journal 330:1099-1110
314. Smith M (2007) To End an Epidemic: A Study of Foreign Aid and HIV/AIDS. International Relations Thesis, New York University
315. Steenhuysen J (2007) U.S. Regulators Join HIV Transplant Probe. Reuters 16 November 2007
316. Stein E (2001) International integration and democracy: No love at first sight. American Journal of International Law 95:489
317. Stobbaerts E (2007) Yet Another Arrogant Move? MSF's Stance on its Relationship with the Rest of the International Aid System. http://www.msf.org/ msfinternational/invoke. cfm?objectid=EE64610A-15C5-F00A- 259987366CDE871D&component=toolkit. article&method=full-html. Accessed 14 November 2007
318. Taylor AL (2004) Governing the Globalization of Public Health. J Law Med Ethics 32:500-508 (Pubitemid 39334805)
319. The Economist (2007) Time to Grow up: "Abstinence only" Education does not Slow the Spread of AIDS. http://www.economist.com/ displaystory.cfm?story-id=9831189. Accessed 20 September 2007
320. Turner J (1997) For WHO or For Whom? World Health Organization's Influence on Health Policy. Lancet 7:1639
321. UNAIDS (2005a) Intensifying HIV Prevention: UNAIDS Policy Position Paper. http://data.unaids.org/governance/pcb04/pcb-17-05-03-en.pdf. Accessed 25 May 2007
322. UNAIDS (2005b) Resource Needs for an Expanded Response to AIDS in Low-and Middle-Income Countries. http://www.unaids.org/en/Coordination/FocusAreas/ Strategic Information.asp. Accessed 25 June 2007
323. Underhill K, Operario D, Montgomery P (2007) Systematic Review of Abstinence-Plus HIV Prevention Programs in High-Income Countries. Public Library of Science Medicine 4(9)
324. USAID (2005) Acquisition and Assistance Policy Directive 05-04, Eligibility Limitation on the Use of Funds and Opposition to Prostitution and Sex Trafficking, http://www.usaid.gov/business/business-opportunities/cib/pdf/ aapd05-04.pdf. Accessed 5 August 2007
325. US Department of State (2006) HIV Prevention among Drug Users Guidance #1: Injection Heroin Use (March 2006). http://www.state.gov/s/gac/partners/ guide/prevent/64035. htm. Accessed 25 October 2007
326. von Tigerstrom B (2005) The revised international health regulations and restraint of national health measures. Health Law Journal 13:35
327. World Health Organization (2004) Effectiveness of Sterile Needle and Syringe Programming in Reducing HIV/AIDS Among Injecting Drug Users
328. AIDS Treatment News (1991) Travel/Immigration Ban: Background, Documentation. http://www.aids.org/atn/a-128-03.html. Accessed 5 December 2007
329. Associated Press (1995) Senator Jesse Helms: Cut AIDS Funding. http://ww2.aegis.org/news/ap/1995/AP950702.html. Accessed 1 December 2007
330. Associated Press (2007) Experimental AIDS vaccine falls short. 21 September 2007
331. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A (2005) Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: The ANRS 1265 trial. PLoS Medicine 2:298
332. Avilés Allende C (2007) Amplía Corte protección a militares con VIH. El Universal, 24 September 2007. http://www.el-universal.com. mx/notas/450935.html. Accessed 10 December 2007
333. Bailey RC (2007) Male Circumcision: The Road from Evidence to Practice. Division of Epidemiology, School of Public Health, University of Illinois at Chicago
334. Betteridge G (2007) Criminal law and HIV transmission or exposure: New cases and developments. HIV/AIDS Policy and Law Review 12:40-44
335. Burris, S (1999) Law as a structural factor in the spread of communicable disease. Houston Law Review 36:1755
336. Burris S, Beletsky L, Burleson JA, Case P, Lazzarini Z (2007) Do Criminal Laws Influence HIV Risk Behavior? An Empirical Trial. http://ssrn.com/abstract= 977274. Accessed 5 November 2007
337. Canadian AIDS Society (2004) HIV Disclosure & the Criminal Law in Canada. http://www.aidslaw.ca/publications/interfaces/downloadFile.php?ref=24. Accessed 15 November 2007
338. Canadian HIV/AIDS Legal Network (2003) Supreme Court of Canada Decision in R v. Williams. http://www.aidslaw.ca/publications/interfaces/downloadFile. php?ref=22. Accessed 25 November 2007
339. Canadian HIV/AIDS Legal Network (2007a) Canada's Immigration Policy as it Affects People Living with HIV/AIDS, February 2007. http://www.aidslaw.ca/ publications/interfaces/downloadFile.php?ref=1254. Accessed 5 November 2007
340. Canadian HIV/AIDS Legal Network (2007b) A Human Rights-based Commentary on UNAIDS Guidance Note: HIV and Sex Work. http://www.hivlawandpolicy.org/ resources/A%20Human%20Rights-based%20Commentary%20on % 20UNAIDS %20Guidance% 20 on %20Sex%20Work%20&%20HIV-sept%2007.pdf. Accessed 5 November 2007
341. Carballo M (2007) Communicable Diseases: Challenges for Health in the Age of Migration. http://www.eu2007.min-saude.pt/NR/rdonlyres/84DA4983-F26D-4C53- 899A-A9138 2C1FE1C/10624/Chpt4EU.PDF. Accessed 7 November 2007
342. CHAI (2007) Q & A on Second-Line HIV/AIDS Treatment. http://www.cptech.org/ip/health/aids/2g/clinton-qa05082007.pdf. Accessed 5 November 2007
343. Cochrane J (2000) Zidovudine's patent history. Lancet 356:1611-1612
344. Coffey S, Peiperl L (2006) Zidovudine. http://hivinsite.ucsf.edu/InSite? page=ar-01-01. Accessed 5 November 2007
345. Dunham W (2007) AIDS virus weakness detected. Reuters, 14 February 2007
346. Economist (2006) Look to the future: The war against AIDS. The Economist, 19 August 2006
347. Economist (2008) Net benefits: Giving bed nets and drugs away free may be the way to deal with malaria. The Economist, 31 January 2008
348. Elliot R (2002) Criminal Law, Public Health and HIV Transmission: A Policy Options Paper. http://data.unaids.org/publications/IRC-pub02/JC733- CriminalLaw-en.pdf. Accessed 15 November 2007
349. Elliott R, Gold J (2005) Protection against discrimination based on HIV/AIDS status in Canada: The legal framework. HIV/AIDS Policy and Law Review 10:1
350. Epstein H (2007) The Invisible Cure: Africa, the West, and the Fight Against AIDS. London, Farrar, Straus and Giroux
351. French R, Brocklehurst P (1998) The effect of pregnancy on survival in women infected with HIV: A systematic review of the literature and meta-analysis. British Journal of Obstetrics and Gynaecology VI: 105(IP: 8):827-835 (Pubitemid 28423497)
352. Global HIV Prevention Working Group (2007) Bringing HIV Prevention to Scale: An Urgent Global Priority. http://www.icaso.org/resources/bringing-HIV- prev-to-scale-2007. pdf. Accessed 5 November 2007
353. GMHC (2006) To All HIV Positive Visitors Coming to the United States to Attend the 2006 High Level Meeting on AIDS. http://www.ua2010.org/index.php/en/ content/download/2400/24423/file/ 2006%20High%20Level%20Meeting%20on%20AIDS%20HIV %20Waiver.pdf. Accessed 25 November 2007
354. Gratham N (2007) A Salute to the Sisters. Promise Fall/Winter 2007, St. Paul's Foundation
355. Gruskin S, Mills E, Tarantola D (2007) History, principles and practice of health and human rights. Lancet 370:449-455 (Pubitemid 47176659)
356. Halperin D (2007) Evidence-Based Behavior Change HIV Prevention Approaches for Sub-Saharan Africa. Harvard Center for Population and Development Studies. http://www.harvardaidsprp.org/research/daniel-halperin-hupa-011707. pdf. Accessed 5 December 2007
357. Hamied YK (2005) Trading in Death. Health Administrator XIX:1
358. Hammer et al. (2006) Treatment for Adult HIV Infection: 2006 Recommendations of the International AIDS Society-USA Panel. JAMA 296:827-843 (Pubitemid 44223106)
359. Harvard School of Public Health Program on International Health and Human Rights (2006) HIV/AIDS and Gender-Based Violence (GBV), Literature Review. http://www.hsph.harvard.edu/pihhr/files/Final-Literature-Review.pdf. Accessed 5 November 2007
360. Hulse C (2005) In Memoir, Jesse Helms Says He Was No Racist. http://www.nytimes. com/2005/08/31/politics/31helms.html?-r=1&oref=slogin. Accessed 25 November 2007
361. Human Rights Watch (2004) Lessons Not Learned: Human Rights Abuses and HIV/AIDS in the Russian Federation. http://hrw.org/reports/2004/russia0404/. Accessed 15 November 2007
362. Human Rights Watch (2006) Family, Unvalued: Discrimination, Denial, and the Fate of Binational Same-Sex Couples under U.S. Law. http://hrw.org/reports/ 2006/us0506/. Accessed 8 November 2007
363. Hulse C (2005) In Memoir, Jesse Helms Says He Was No Racist. http://www.nytimes. com/2005/08/31/politics/31helms.html?-r=1&oref=slogin. Accessed 25 November 2007
364. Human Rights Watch (2004) Lessons Not Learned: Human Rights Abuses and HIV/AIDS in the Russian Federation. http://hrw.org/reports/2004/russia0404/. Accessed 15 November 2007
365. Human Rights Watch (2006) Family, Unvalued: Discrimination, Denial, and the Fate of Binational Same-Sex Couples under U.S. Law. http://hrw.org/reports/ 2006/us0506/. Accessed 8 November 2007
366. IB Times (2007) Gilead, Bristol-Myers to Market HIV Drug. http://www.ibtimes.com/articles/20071211/gilead-bristol-myers-to-market-hiv- drug.htm. Accessed 5 November 2007
367. John Gill Smith and United States v. City of Philadelphia (2006) Settlement Order. http://www.hivlawandpolicy.org/resources/settlement%20order- EMTS-Phila%20Nov%202006.pdf. Accessed 25 November 2007
368. Jürgens R (2007) Increasing access to HIV testing and counseling while respecting human rights. New York, Public Health Program of the Open Society Institute
369. Jürgens R, Cohen J (2007) Human Rights and HIV/AIDS: Now More Than Ever, 10 Reasons Why Human Rights Should Occupy the Center of the Global AIDS Struggle. Open Society Institute. http://www.soros.org/initiatives/health/focus/ law/articles
370. Kelly C (2004) Conspiring to kill: gender-biased legislation, culture, and aids in sub-Saharan Africa. Journal of Law and Family Studies 6:439
371. Kershaw S (2008) New HIV Cases Drop but Rise in Young Gay Men. www.nytimes. com. Accessed 2 January 2008
372. Klein A (2007) Criminal law and HIV/AIDS. HIV/AIDS Policy and Law Review 12: 51-53
373. Koch E (1987) Senator Helms's Callousness Toward AIDS Victims. http://query. nytimes. com/gst/fullpage.html?res= 9B0DE3DA1530F934A35752C1A961948260. Accessed 25 November 2007
374. Latino Commission on AIDS (2007) The Latino Commission on AIDS Supports the HIV Nondiscrimination in Travel and Immigration Act. http://www.latinoaids. org/mediaadvisory/travel.htm. Accessed 11 November 2007
375. Medina A, Reyes MA (2007) Discriminación por vivir con VIH: Fuerzas Armadas, a punto del revés, Letra S 128. http://www.jornada.unam. mx/2007/03/01/ls-fuerzasarmadas. html. Accessed 2 December 2007
376. Millett G, Peterson J (2007) The known hidden HIV/AIDS epidemic among Black men who have sex with men in the United States. American Journal of Preventive Medicine 32:31-33 (Pubitemid 46454438)
377. Montefiori D et al. (2007) Antibody-based HIV-1 vaccine: Recent developments and future directions. PLoS Medicine 4:12
378. NYC Health (2007) HIV Epidemiology and Field Services Research Unit Report, October 2007. http://www.nyc.gov/html/doh/downloads/pdf/dires/dires- 2007-research-report. pdf. Accessed 12 December 2007
379. OECD (2006) OECD Health Data 2006. http://www.oecd.org/health/healthdata. Accessed 5 January 2008
380. Ohio v. Bird (1998) Ohio State Court Appellate Amicus Brief. http://www.hivlawandpolicy.org/resources/ Larry%20Bird%20Amicus%20Appellate%20Brief.pdf. Accessed 20 December 2007
381. Oster E (2005) Sexually transmitted infections, sexual behavior, and the HIV/AIDS epidemic. The Quarterly Journal of Economics120(2):467-514
382. Park A (2007) Assessing a Failed AIDS Vaccine. http://www.time.com/time/ health/article/0, 8599, 1681526, 00.html?xid=feed-cnn-topics. Accessed 12 December 2007
383. Pearshouse R (2007) Mexico: Supreme court rules discharge of HIV-positive troops unconstitutional. HIV/AIDS Policy and Law Review 12:47-48
384. Peeters M, Sharp PM (2000) Genetic diversity of HIV-1: The moving target. AIDS 14:S129-S130
385. Pérez-Casas C et al. (2000) HIV/AIDS Pricing Report. Médicins sans Frontières. http://www.bioltrop.fr/09-diagautre/ durban-hiv.htm. Accessed 7 December 2007
386. Perry A (2007) Seeds of Change in Rwanda. Time/CNN, 26 September 2007. http://www.ambassadorprograms.org/upcomingprograms/extensions/2008/time-rwanda. pdf. Accessed 2 December 2007
387. R v. Cuerrier (1998) 2 SCR 371, Supreme Court of Canada. http://scc.lexum.umontreal. ca/en/1998/1998rcs2-371/1998rcs2-371.html. Accessed 12 December 2007
388. R v. Williams (2003) 2 SCR 134, Supreme Court of Canada. http://scc.lexum.umontreal. ca/en/2003/2003scc41/2003scc41.html. Accessed 22 December 2007
389. SCJN (2007a) Sesión Pública Núm. 27, Amparo en revisión 510/2004. http://www.scjn.gob.mx/NR/rdonlyres/F8F3CE48-E2D1- 4A3A-BEEE-594EA57353B0/0/276 MARDE2007.pdf. Accessed 2 December 2007
390. SCJN (2007b) Sesión Pública Núm. 26, Amparo en revisión 510/2004. http://www.scjn. gob.mx/NR/rdonlyres/98EF667E-CF50- 4ABB-AB9F-107ADF012927/0/265DEMARZODE 2007.pdf. Accessed 2 December 2007
391. Singh JA, Govender M, Mills E (2007) Do human rights matter to health? Lancet 370:521-527 (Pubitemid 47225105)
392. State v. Jones (2000) New Mexico Court of Appeals, 129 NM 165. http://www.hivlawandpolicy.org/resources/State%20v%20Jones%20- %20NM%20spitting%20case-2000.pdf. Accessed 4 December 2007
393. Tarantola D, Gruskin S (2007) New guidance on recommended HIV testing and couselling. Lancet 370:202-203 (Pubitemid 47069520)
394. Tarwater J (2001) The tuberculosis & HIV debate in immigration law: Critical flaws in United States academic anti-exclusion arguments. Georgetown
395. US Food and Drug Administration (2006) Guidance for Industry Fixed Dose Combinations, Co-Packaged Drug Products, and Single-Entity Versions of Previously Approved Antiretrovirals for the Treatment of HIV. http://www.fda.gov/cder/guidance/6360fnl.htm. Accessed 8 December 2007
396. Weeks v. State (1992) Texas Court of Appeal, 834 SW 2d 559. http://www.hivlawandpolicy.org/resources/partial %20case %20&resource %20 list-Lambda.pdf. Accessed 4 December 2007
397. Werner E (2007) Lawmakers, Gay-Rights Groups Protesting New HIV/AIDS Travel Rule in US. http://news.lp.findlaw.com/ap/o/55/12-11-2007/ f0a90026bc21dacb.html. Accessed 2 December 2007
398. WHO (2006) Progress on Global Access to HIV Antiretroviral Therapy: A Report on "3 by 5" and Beyond. www.who.int/hiv/fullreport-en-highres. pdf. Accessed 9 December 2007
399. UNAIDS/IOM (2004) Statement on HIV/AIDS-Related Travel Restrictions. http://www.aegis.com/files/unaids/UNAIDS-IOM-on %20travel%20restrictions.pdf. Accessed 2 December 2007
400. UNAIDS (2006) Report on the Global AIDS Epidemic. http://www.unaids.org/ en/HIV-data/2006GlobalReport/default.asp. Accessed 22 November 2007
401. UNAIDS (2007) UNAIDS Guidance Note HIV and Sex Work. http://www.aids.md/ files/library/2007/1144/unaids-guidance-note-hiv-sex-work-apr-2007.pdf. Accessed 2 December 2007
402. Underhill K, Operario D, Montgomery P (2007) Systematic Review of Abstinence-Plus HIV Prevention Programs in High-Income Countries. PLoS Medicine 4:9
403. United Nations (2007) International Guidelines on HIV/AIDS and Human Rights: 2006 Consolidated Version. http://data.unaids.org/Publications/IRC- pub07/jc1252-internguidelines-en.pdf. Accessed 5 December 2007
404. Urbina I (2007) New Law Allows Needle Exchanges in Washington. http://www.nytimes. com. Accessed 27 December 2007
405. World Health Organization (2003) Scaling Up Antiretroviral Therapy in Resouurce-Limited Setting: Treatment Guidelines for a Public Health Approach. http://www.who.int/hiv/pub/prev-care/en/arvrevision2003en.pdf. Accessed 20 November 2007
406. Zowall et al. (1994) Modeling Health Care Costs Attributable to HIV Infection and Coronary Heart Disease in Immigrants to Canada. In: Kaplan, Brandeau (eds) Modeling the AIDS Epidemic-Planning, Policy and Predictions. Raven Press, New York